Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 42kWORD 9k
17 November 2020
P-006241/2020
Priority question for written answer  P-006241/2020
to the Commission
Rule 138
Asger Christensen (Renew), Morten Løkkegaard (Renew), Søren Gade (Renew)
 Subject: Occurrence of new mink variants of COVID-19 in Denmark

In Denmark, COVID-19 outbreaks on at least 216 mink farms have been recorded. The Danish health authorities have found new mink variants of COVID-19 in a number of infected persons. One such variant is designated ‘cluster 5’. According to Danish health authorities, the existence of ‘cluster 5’ may mean that a prospective COVID-19 vaccine will be less efficacious, as it may potentially reduce the effect of antibodies. On 4 November 2020, accordingly, the Danish Government decided that all mink herds in Denmark should be culled.

1. Is the Commission aware of the occurrence of new mink variants of COVID-19 in Denmark, and is it also the Commission’s judgement that the ‘cluster 5’ mutation may make a prospective COVID-19 vaccine less efficacious? If it is, what is the scientific basis for that judgement?

2. Will there be EU-level follow-up studies on the ‘cluster 5’ and other mink variants of COVID-19 so as to verify the Danish health authorities’ scientific evidence?

3. Lastly, is the Commission aware of similar drastic measures taken by other EU Member States?

Original language of question: DA
Last updated: 19 November 2020Legal notice - Privacy policy